par Efficace, F;Therasse, P.;Piccart-Gebhart, Martine ;Coens, C;Van Steen, K;Welnicka-Jaskiewicz, M;Cufer, T;Dyczka, Jaroslaw;Lichinitser, Michail;Shepherd, L;de Haes, Hanneke;Sprangers, Mirjam A;Bottomley, A
Référence Journal of clinical oncology, 22, 16, page (3381-3388)
Publication Publié, 2004-08
Référence Journal of clinical oncology, 22, 16, page (3381-3388)
Publication Publié, 2004-08
Article révisé par les pairs
Titre: |
|
Auteur: | Efficace, F; Therasse, P.; Piccart-Gebhart, Martine; Coens, C; Van Steen, K; Welnicka-Jaskiewicz, M; Cufer, T; Dyczka, Jaroslaw; Lichinitser, Michail; Shepherd, L; de Haes, Hanneke; Sprangers, Mirjam A; Bottomley, A |
Informations sur la publication: | Journal of clinical oncology, 22, 16, page (3381-3388) |
Statut de publication: | Publié, 2004-08 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- pathology | |
Cyclophosphamide -- administration & dosage | |
Disease-Free Survival | |
Epirubicin -- administration & dosage | |
Female | |
Fluorouracil -- administration & dosage | |
Granulocyte Colony-Stimulating Factor -- administration & dosage | |
Health Status | |
Humans | |
Inflammation | |
Middle Aged | |
Predictive Value of Tests | |
Prognosis | |
Quality of Life | |
Note générale: | Clinical Trial |
Clinical Trial, Phase III | |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
Research Support, U.S. Gov't, P.H.S. | |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2004.02.060 | |
info:pii/22/16/3381 | |
info:pmid/15310784 |